These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 12869536)
1. Basis of a high-throughput method for nuclear receptor ligands. Kanayama T; Mamiya S; Nishihara T; Nishikawa J J Biochem; 2003 Jun; 133(6):791-7. PubMed ID: 12869536 [TBL] [Abstract][Full Text] [Related]
2. New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Nishikawa J; Saito K; Goto J; Dakeyama F; Matsuo M; Nishihara T Toxicol Appl Pharmacol; 1999 Jan; 154(1):76-83. PubMed ID: 9882594 [TBL] [Abstract][Full Text] [Related]
3. Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2. Leers J; Treuter E; Gustafsson JA Mol Cell Biol; 1998 Oct; 18(10):6001-13. PubMed ID: 9742117 [TBL] [Abstract][Full Text] [Related]
4. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer. Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982 [TBL] [Abstract][Full Text] [Related]
5. Multiple receptor interaction domains of GRIP1 function in synergy. Schmidt S; Baniahmad A; Eggert M; Schneider S; Renkawitz R Nucleic Acids Res; 1998 Mar; 26(5):1191-7. PubMed ID: 9469826 [TBL] [Abstract][Full Text] [Related]
6. Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands. Ferry G; Bruneau V; Beauverger P; Goussard M; Rodriguez M; Lamamy V; Dromaint S; Canet E; Galizzi JP; Boutin JA Eur J Pharmacol; 2001 Apr; 417(1-2):77-89. PubMed ID: 11301062 [TBL] [Abstract][Full Text] [Related]
7. High-throughput system for analyzing ligand-induced cofactor recruitment by vitamin D receptor. Arai MA; Takeyama K; Ito S; Kato S; Chen TC; Kittaka A Bioconjug Chem; 2007; 18(3):614-20. PubMed ID: 17408240 [TBL] [Abstract][Full Text] [Related]
8. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. Voegel JJ; Heine MJ; Tini M; Vivat V; Chambon P; Gronemeyer H EMBO J; 1998 Jan; 17(2):507-19. PubMed ID: 9430642 [TBL] [Abstract][Full Text] [Related]
9. Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205. Maeda Y; Rachez C; Hawel L; Byus CV; Freedman LP; Sladek FM Mol Endocrinol; 2002 Jul; 16(7):1502-10. PubMed ID: 12089346 [TBL] [Abstract][Full Text] [Related]
10. A regulatory role for RIP140 in nuclear receptor activation. Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662 [TBL] [Abstract][Full Text] [Related]
11. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant. Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208 [TBL] [Abstract][Full Text] [Related]
12. Effect of ligand and DNA binding on the interaction between human transcription intermediary factor 1alpha and estrogen receptors. Thénot S; Bonnet S; Boulahtouf A; Margeat E; Royer CA; Borgna JL; Cavaillès V Mol Endocrinol; 1999 Dec; 13(12):2137-50. PubMed ID: 10598587 [TBL] [Abstract][Full Text] [Related]
16. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Dutertre M; Smith CL Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702 [TBL] [Abstract][Full Text] [Related]
17. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping. Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595 [TBL] [Abstract][Full Text] [Related]
18. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators. Lopez GN; Webb P; Shinsako JH; Baxter JD; Greene GL; Kushner PJ Mol Endocrinol; 1999 Jun; 13(6):897-909. PubMed ID: 10379889 [TBL] [Abstract][Full Text] [Related]
19. Characterization of activating signal cointegrator-2 as a novel transcriptional coactivator of the xenobiotic nuclear receptor constitutive androstane receptor. Choi E; Lee S; Yeom SY; Kim GH; Lee JW; Kim SW Mol Endocrinol; 2005 Jul; 19(7):1711-9. PubMed ID: 15764585 [TBL] [Abstract][Full Text] [Related]
20. Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2. Lee SK; Jung SY; Kim YS; Na SY; Lee YC; Lee JW Mol Endocrinol; 2001 Feb; 15(2):241-54. PubMed ID: 11158331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]